Cardiac Myxoma and Cerebrovascular Events: A Retrospective Cohort Study

Background: Cardiac myxoma (CM) is the most frequent, cardiac benign tumor and is associated with enhanced risk for cerebrovascular events (CVE). Although surgical CM excision is the only curative treatment to prevent CVE recurrence, in recent reports conservative treatment with antiplatelet or anticoagulant agents in high-risk patients with CM-related CVE has been discussed. Methods: Case records at the University Hospital of Tübingen between 2005 and 2017 were screened to identify patients with CM-related CVE. Clinical features, brain and cardiac imaging findings, histological reports, applied treatments and long-term neurological outcomes were assessed. Results: 52 patients with CM were identified and among them, 13 patients with transient ischemic attack, ischemic stroke or retinal ischemia were included to the (to our knowledge) largest reported retrospective study of CM-related CVE. In all identified patients, CVE was the first manifestation of CM; 61% suffered ischemic stroke, 23% transient ischemic attack and 15% retinal ischemia. In 46% of the patients, CVE occurred under antiplatelet or anticoagulation treatment, while 23% of the patients developed recurrent CVE under bridging-antithrombotic-therapy prior to CM surgical excision. Prolonged time interval between CVE and CM-surgery was significantly associated with CVE recurrence (p = 0.021). One patient underwent i.v. thrombolysis, followed by thrombectomy, with good post-interventional outcome and no signs of hemorrhagic transformation. Discussion: Our results suggest that antiplatelet or anticoagulation treatment is no alternative to cardiac surgery in patients presenting with CM-related CVE. We found significantly prolonged time-intervals between CVE and CM surgery in patients with recurrent CVE. Therefore, we suggest that the waiting- or bridging-interval with antithrombotic therapy until curative CM excision should be kept as short as possible. Based on our data and review of the literature, we suggest that in patients with CM-related CVE, i.v. thrombolysis and/or endovascular interventions may present safe and efficacious acute treatments.

[1]  E. Yuliwati,et al.  A Review , 2019, Current Trends and Future Developments on (Bio-) Membranes.

[2]  M. Dąbrowski,et al.  A large tumour of the left atrium - A 10-year follow-up. , 2016, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[3]  A. Alexandrov,et al.  The value of transesophageal echocardiography for embolic strokes of undetermined source , 2016, Neurology.

[4]  Hai-zhou Zhang,et al.  Risk prediction for emboli and recurrence of primary cardiac myxomas after resection , 2016, Journal of Cardiothoracic Surgery.

[5]  S. Yuan,et al.  Stroke of a cardiac myxoma origin , 2015, Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular.

[6]  K. Ikeda,et al.  Case Report and Discussion , 2015 .

[7]  M. Acampa,et al.  Thrombolytic treatment of cardiac myxoma-induced ischemic stroke: a review. , 2014, Current drug safety.

[8]  E. Fleck,et al.  T1 and T2 mapping for tissue characterization of cardiac myxoma. , 2013, International journal of cardiology.

[9]  A. Qureshi,et al.  Thrombolysis for Ischemic Stroke Associated With Infective Endocarditis: Results From the Nationwide Inpatient Sample , 2013, Stroke.

[10]  Saleh Baeesa,et al.  Emergency Excision of Cardiac Myxoma and Endovascular Coiling of Intracranial Aneurysm after Cerebral Infarction , 2013, Case reports in neurological medicine.

[11]  A. Boutayeb,et al.  Right atrial myxoma and severe left ventricular dysfunction: which explanations? Which management? , 2013, Heart, lung & circulation.

[12]  B. Biočina,et al.  Cardiac myxoma the great imitators: comprehensive histopathological and molecular approach. , 2013, International journal of cardiology.

[13]  E. Erdmann,et al.  Local Thrombolysis for Successful Treatment of Acute Stroke in an Adolescent with Cardiac Myxoma , 2011, TheScientificWorldJournal.

[14]  Mu-Chien Sun,et al.  Intravenous Thrombolysis for Embolic Stroke due to Cardiac Myxoma , 2011, Case Reports in Neurology.

[15]  C. Ong,et al.  Intravenous Thrombolysis of Occlusion in the Middle Cerebral and Retinal Arteries from Presumed Ventricular Myxoma , 2010, Stroke research and treatment.

[16]  D. Yuh,et al.  Safe and effective intravenous thrombolysis for acute ischemic stroke caused by left atrial myxoma. , 2009, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[17]  W.,et al.  Cardiac myxoma metastasizing to the brain , 2009 .

[18]  M. Kaste,et al.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.

[19]  D. McPherson,et al.  Biatrial myxoma and cerebral ischemia successfully treated with intravenous thrombolytic therapy and surgical resection. , 2008, Texas Heart Institute journal.

[20]  R. Barik,et al.  Clinical presentation and investigation findings in cardiac myxomas: new insights from the developing world. , 2007, American heart journal.

[21]  Robert D. Brown,et al.  Central nervous system manifestations of cardiac myxoma. , 2007, Archives of neurology.

[22]  Mitchell S. V. Elkind,et al.  Intravenous thrombolytic treatment of acute ischemic stroke associated with left atrial myxoma: a case report. , 2005, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[23]  G. Donnan,et al.  Neurological manifestations of cardiac myxoma: a review of the literature and report of cases , 2004, Internal medicine journal.

[24]  J. Robin,et al.  Changing management of cardiac myxoma based on a series of 40 cases with long-term follow-up. , 2003, The Annals of thoracic surgery.

[25]  A. Shuaib,et al.  Atrial myxoma as a cause of stroke: case report and discussion. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[26]  W. Schima,et al.  Usefulness of magnetic resonance imaging of cardiac and paracardiac masses. , 2003, The American journal of cardiology.

[27]  P. Rehak,et al.  Cardiac myxomas: 24 years of experience in 49 patients. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[28]  R. Loire,et al.  Clinical Presentation of Left Atrial Cardiac Myxoma: A Series Of 112 Consecutive Cases , 2001, Medicine.

[29]  J. Bernarding,et al.  Scattered Brain Infarct Pattern on Diffusion-Weighted Magnetic Resonance Imaging in Patients with Acute Ischemic Stroke , 2001, Cerebrovascular Diseases.

[30]  K. Yoshida,et al.  [Superselective fibrinolysis for a middle cerebral artery embolism caused by a left atrial myxoma: case report]. , 2000, No shinkei geka. Neurological surgery.

[31]  V. Jebara,et al.  [Recurrent cerebrovascular accident: unusual and isolated manifestation of myxoma of the left atrium]. , 1999, Le Journal medical libanais. The Lebanese medical journal.

[32]  N. Ratliff,et al.  Intra-arterial thrombolysis of embolic proximal middle cerebral artery occlusion from presumed atrial myxoma , 1997, Neurology.

[33]  D. C. Henckel,et al.  Case report. , 1995, Journal.

[34]  J. Parisi,et al.  Fulminant Brain Necrosis From Atrial Myxoma Showers , 1993, Stroke.

[35]  K. Reynen,et al.  Cardiac myxomas. , 1995, The New England journal of medicine.

[36]  E. Cordero,et al.  [Cardiac myxoma. A report of 23 cases]. , 1992, Gaceta medica de Mexico.

[37]  L. Johansson Histogenesis of cardiac myxomas. An immunohistochemical study of 19 cases, including one with glandular structures, and review of the literature. , 1989, Archives of pathology & laboratory medicine.

[38]  H. Adams,et al.  Neurologic manifestations of atrial myxoma. A 12-year experience and review. , 1988, Stroke.

[39]  J. Cunningham,et al.  Results of open heart surgery in patients with recent cardiogenic embolic stroke and central nervous system dysfunction. , 1987, Circulation.

[40]  L. Dogliotti,et al.  [Male breast carcinoma. Review of the literature and report of cases]. , 1982, Minerva chirurgica.

[41]  L. Wold,et al.  Cardiac myxomas: a clinicopathologic profile. , 1980, The American journal of pathology.

[42]  M. G. St. John Sutton,et al.  Atrial myxomas: a review of clinical experience in 40 patients. , 1980, Mayo Clinic proceedings.

[43]  A. Greco,et al.  Malignant cardiac myxoma with cerebral metastases. , 1979, Surgical neurology.

[44]  A. Damasio,et al.  Multiple cerebral aneurysms and cardiac myxoma. , 1975, Archives of neurology.

[45]  C. Burton,et al.  Multiple cerebral aneurysms and cardiac myxoma. , 1970, The New England journal of medicine.